A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder.
Phase of Trial: Phase III
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Duloxetine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 05 Mar 2012 Actual patient number (337) added as reported by ClinicalTrials.gov.
- 14 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.